» Articles » PMID: 17965716

Natural Killer Cell Trafficking in Vivo Requires a Dedicated Sphingosine 1-phosphate Receptor

Overview
Journal Nat Immunol
Date 2007 Oct 30
PMID 17965716
Citations 190
Authors
Affiliations
Soon will be listed here.
Abstract

Consistent with their function in immune surveillance, natural killer (NK) cells are distributed throughout lymphoid and nonlymphoid tissues. However, the mechanisms governing the steady-state trafficking of NK cells remain unknown. The lysophospholipid sphingosine 1-phosphate (S1P), by binding to its receptor S1P1, regulates the recirculation of T and B lymphocytes. In contrast, S1P5 is detected in the brain and regulates oligodendrocyte migration and survival in vitro. Here we show that S1P5 was also expressed in NK cells in mice and humans and that S1P5-deficient mice had aberrant NK cell homing during steady-state conditions. In addition, we found that S1P5 was required for the mobilization of NK cells to inflamed organs. Our data emphasize distinct mechanisms regulating the circulation of various lymphocyte subsets and raise the possibility that NK cell trafficking may be manipulated by therapies specifically targeting S1P5.

Citing Articles

Intrathymic Cell Migration: Implications in Thymocyte Development and T Lymphocyte Repertoire Formation.

Mendes-da-Cruz D, Lemos J, Belorio E, Savino W Adv Exp Med Biol. 2025; 1471:139-175.

PMID: 40067586 DOI: 10.1007/978-3-031-77921-3_5.


Regulatory role of S1P and its receptors in sepsis-induced liver injury.

Wang B, Wu X, Cheng J, Ye J, Zhu H, Liu X Front Immunol. 2025; 16:1489015.

PMID: 39935473 PMC: 11811114. DOI: 10.3389/fimmu.2025.1489015.


The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers.

Liu B, Zhou J, Jiang B, Tang B, Liu T, Lei P Front Immunol. 2024; 15:1511283.

PMID: 39650647 PMC: 11621088. DOI: 10.3389/fimmu.2024.1511283.


Interferon gamma-mediated prevention of tumor progression in a mouse model of multiple myeloma.

Kellermayer Z, Tahri S, de Jong M, Papazian N, Fokkema C, Stoetman E Hemasphere. 2024; 8(12):e70047.

PMID: 39624831 PMC: 11609740. DOI: 10.1002/hem3.70047.


Unique pharmacological properties of etrasimod among S1P receptor modulators.

Gaidarov I, Komori H, Stepniak D, Bruinsma K, Dang H, Chen X FEBS Open Bio. 2024; 15(1):108-121.

PMID: 39564958 PMC: 11705451. DOI: 10.1002/2211-5463.13907.